お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、医薬品添加剤の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に医薬品添加剤市場を分類しています。
本レポートでは世界の医薬品添加剤市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：DowDuPont (FMC)、JRS Pharma、BASF、Lubrizol、Ashland、Croda International、Roquette、Shin-Etsu、Evonik、Associated British Foods、Südzucker AG、Mitsubishi、Hunan ER-KANG、Anhui Sunhere、Tianjin Chase Sun、Xiwang Group、ShengTai Group、Nanjing Well Pharmaceutical

レポートは医薬品添加剤の主要生産者を調査し、主要地域や国の消費状況も提供します。医薬品添加剤の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Starch and Derivatives
    Sucrose
    Cellulose and Derivatives
    Dextrose
    Polyols
    Inorganic Salts
    Others

用途別の市場セグメント：
    Oral Formulations
    Topical Formulations
    Parenteral Formulations
    Other

本レポートの詳細内容
本レポートは、世界の医薬品添加剤市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて医薬品添加剤市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の医薬品添加剤生産量、成長率、市場シェアを調査している。

二. 消費面では、医薬品添加剤の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの医薬品添加剤売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の医薬品添加剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本医薬品添加剤のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：医薬品添加剤のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 医薬品添加剤の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける医薬品添加剤の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章医薬品添加剤メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：医薬品添加剤の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：医薬品添加剤の主要メーカーの概要を提供し、製品の説明と仕様、医薬品添加剤の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：医薬品添加剤の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Pharmaceutical Excipients market is projected to grow from US$ 47840 million in 2025 to US$ 64590 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period.
The evolving U.S. tariff policy posed substantial volatility risks to global markets. This report provides a comprehensive assessment of trade barrier escalations and cross-border counterstrategies, analyzing their multidimensional impacts on industrial competition patterns, geo-economic integration, and transnational value chain realignments.
Pharmaceutical excipients are substances that are included in a pharmaceutical dosage form not for their direct therapeutic action, but to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability.

Global Pharmaceutical Excipients key players include Hnerkang、DowDuPont (FMC)、JRS Pharma、BASF、Lubrizol、Ashland、Croda International、Roquette、Shin-Etsu、Evonik, etc. Global top ten manufacturers hold a share about 7%. North America is the largest market, with a share about 35%, followed by Europe and Asia Pacific, have a share over 60 percent. 
With the continuous progress and innovation of the pharmaceutical industry, the market demand for pharmaceutical excipients is also growing. Especially in the context of the improvement of global health awareness, the intensification of an aging society, and the increasing demand for efficient and safe drugs, the application scenarios of pharmaceutical excipients are becoming more and more extensive, and the market demand is expanding.
With the rise of new treatment methods such as biopharmaceuticals, personalized drugs, and targeted therapy, higher requirements are placed on the functions and performance of pharmaceutical excipients. For example, biologics and targeted drugs require specific excipients to improve the stability of drugs, improve the efficacy, or prolong the release time of drugs. In addition, the improvement of regulations and the improvement of industry standards have also promoted the standardized development of the pharmaceutical excipients market. In some regions, the government's supervision of drug quality has become more stringent, prompting pharmaceutical companies to pay more attention to quality and safety in the selection of pharmaceutical excipients, thereby promoting the demand for high-performance excipients.
In terms of consumption side, this report focuses on the sales of Pharmaceutical Excipients by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Pharmaceutical Excipients, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Pharmaceutical Excipients, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Pharmaceutical Excipients, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical Excipients sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pharmaceutical Excipients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pharmaceutical Excipients sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including DowDuPont (FMC), JRS Pharma, BASF, Lubrizol, Ashland, Croda International, Roquette, Shin-Etsu, Evonik, Associated British Foods, etc.

Market Segmentation
By Company
    DowDuPont (FMC)
    JRS Pharma
    BASF
    Lubrizol
    Ashland
    Croda International
    Roquette
    Shin-Etsu
    Evonik
    Associated British Foods
    Südzucker AG
    Mitsubishi
    Hunan ER-KANG
    Anhui Sunhere
    Tianjin Chase Sun
    Xiwang Group
    ShengTai Group
    Nanjing Well Pharmaceutical

Segment by Type
    Starch and Derivatives
    Sucrose
    Cellulose and Derivatives
    Dextrose
    Polyols
    Inorganic Salts
    Others

Segment by Application
    Oral Formulations
    Topical Formulations
    Parenteral Formulations
    Other

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pharmaceutical Excipients in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pharmaceutical Excipients manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Excipients sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global Pharmaceutical Excipients Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Major Manufacturers of Starch and Derivatives
 Table 3. Major Manufacturers of Sucrose
 Table 4. Major Manufacturers of Cellulose and Derivatives
 Table 5. Major Manufacturers of Dextrose
 Table 6. Major Manufacturers of Polyols
 Table 7. Major Manufacturers of Inorganic Salts
 Table 8. Major Manufacturers of Others
 Table 9. Global Pharmaceutical Excipients Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 10. Global Pharmaceutical Excipients Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 11. Global Revenue by Region (2020-2025) & (US$ Million)
 Table 12. Global Revenue Market Share by Region (2020-2031)
 Table 13. Global Pharmaceutical Excipients Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Tons)
 Table 14. Global Pharmaceutical Excipients Sales by Region (2020-2031) & (K Tons)
 Table 15. Global Sales Market Share by Region (2020-2031)
 Table 16. Global Pharmaceutical Excipients Sales by Manufacturers (2020-2025) & (K Tons)
 Table 17. Global Pharmaceutical Excipients Sales Share by Manufacturers (2020-2025)
 Table 18. Global Pharmaceutical Excipients Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 19. Global Pharmaceutical Excipients Revenue Market Share by Manufacturers (2020-2025)
 Table 20. Global Key Players of Pharmaceutical Excipients, Industry Ranking, 2023 VS 2024 VS 2024
 Table 21. Pharmaceutical Excipients Price by Manufacturers (2020-2025) & (US$/Ton)
 Table 22. Global Pharmaceutical Excipients Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 23. Global Pharmaceutical Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Excipients as of 2024)
 Table 24. Global Key Manufacturers of Pharmaceutical Excipients, Manufacturing Base Distribution and Headquarters
 Table 25. Global Key Manufacturers of Pharmaceutical Excipients, Product Offered and Application
 Table 26. Global Key Manufacturers of Pharmaceutical Excipients, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Pharmaceutical Excipients Sales by Type (2020-2025) & (K Tons)
 Table 29. Global Pharmaceutical Excipients Sales by Type (2026-2031) & (K Tons)
 Table 30. Global Sales Share by Type (2020-2031)
 Table 31. Global Pharmaceutical Excipients Revenue by Type (2020-2025) & (US$ Million)
 Table 32. Global Pharmaceutical Excipients Revenue by Type (2026-2031) & (US$ Million)
 Table 33. Global Revenue Share by Type (2020-2031)
 Table 34. Pharmaceutical Excipients Price by Type (2020-2025) & (US$/Ton)
 Table 35. Global Pharmaceutical Excipients Price Forecast by Type (2026-2031) & (US$/Ton)
 Table 36. Global Pharmaceutical Excipients Sales by Application (2020-2025) & (K Tons)
 Table 37. Global Pharmaceutical Excipients Sales by Application (2026-2031) & (K Tons)
 Table 38. Global Sales Share by Application (2020-2031)
 Table 39. Global Pharmaceutical Excipients Revenue by Application (2020-2025) & (US$ Million)
 Table 40. Global Pharmaceutical Excipients Revenue by Application (2026-2031) & (US$ Million)
 Table 41. Global Revenue Share by Application (2020-2031)
 Table 42. Pharmaceutical Excipients Price by Application (2020-2025) & (US$/Ton)
 Table 43. Global Pharmaceutical Excipients Price Forecast by Application (2026-2031) & (US$/Ton)
 Table 44. US & Canada Sales by Type (2020-2031) & (K Tons)
 Table 45. US & Canada Revenue by Type (2020-2031) & (US$ Million)
 Table 46. US & Canada Sales by Application (2020-2031) & (K Tons)
 Table 47. US & Canada Revenue by Application (2020-2031) & (US$ Million)
 Table 48. US & Canada Pharmaceutical Excipients Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. US & Canada Revenue by Country (2020-2031) & (US$ Million)
 Table 50. US & Canada Sales by Country (2020-2031) & (K Tons)
 Table 51. Europe Sales by Type (2020-2031) & (K Tons)
 Table 52. Europe Revenue by Type (2020-2031) & (US$ Million)
 Table 53. Europe Sales by Application (2020-2031) & (K Tons)
 Table 54. Europe Revenue by Application (2020-2031) & (US$ Million)
 Table 55. Europe Pharmaceutical Excipients Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 56. Europe Sales by Country (2020-2031) & (K Tons)
 Table 57. Europe Revenue by Country (2020-2031) & (US$ Million)
 Table 58. China Sales by Type (2020-2031) & (K Tons)
 Table 59. China Revenue by Type (2020-2031) & (US$ Million)
 Table 60. China Sales by Application (2020-2031) & (K Tons)
 Table 61. China Revenue by Application (2020-2031) & (US$ Million)
 Table 62. Asia Sales by Type (2020-2031) & (K Tons)
 Table 63. Asia Revenue by Type (2020-2031) & (US$ Million)
 Table 64. Asia Sales by Application (2020-2031) & (K Tons)
 Table 65. Asia Revenue by Application (2020-2031) & (US$ Million)
 Table 66. Asia Pharmaceutical Excipients Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 67. Asia Revenue by Region (2020-2031) & (US$ Million)
 Table 68. Asia Sales by Region (2020-2031) & (K Tons)
 Table 69. Middle East, Africa and Latin America Sales by Type (2020-2031) & (K Tons)
 Table 70. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)
 Table 71. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Tons)
 Table 72. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)
 Table 73. Middle East, Africa and Latin America Pharmaceutical Excipients Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 74. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)
 Table 75. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Tons)
 Table 76. DowDuPont (FMC) Company Information
 Table 77. DowDuPont (FMC) Description and Major Businesses
 Table 78. DowDuPont (FMC) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 79. DowDuPont (FMC) Product Model Numbers, Pictures, Descriptions and Specifications
 Table 80. DowDuPont (FMC) Recent Developments
 Table 81. JRS Pharma Company Information
 Table 82. JRS Pharma Description and Major Businesses
 Table 83. JRS Pharma Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. JRS Pharma Product Model Numbers, Pictures, Descriptions and Specifications
 Table 85. JRS Pharma Recent Developments
 Table 86. BASF Company Information
 Table 87. BASF Description and Major Businesses
 Table 88. BASF Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 89. BASF Product Model Numbers, Pictures, Descriptions and Specifications
 Table 90. BASF Recent Developments
 Table 91. Lubrizol Company Information
 Table 92. Lubrizol Description and Major Businesses
 Table 93. Lubrizol Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 94. Lubrizol Product Model Numbers, Pictures, Descriptions and Specifications
 Table 95. Lubrizol Recent Developments
 Table 96. Ashland Company Information
 Table 97. Ashland Description and Major Businesses
 Table 98. Ashland Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 99. Ashland Product Model Numbers, Pictures, Descriptions and Specifications
 Table 100. Ashland Recent Developments
 Table 101. Croda International Company Information
 Table 102. Croda International Description and Major Businesses
 Table 103. Croda International Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 104. Croda International Product Model Numbers, Pictures, Descriptions and Specifications
 Table 105. Croda International Recent Developments
 Table 106. Roquette Company Information
 Table 107. Roquette Description and Major Businesses
 Table 108. Roquette Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 109. Roquette Product Model Numbers, Pictures, Descriptions and Specifications
 Table 110. Roquette Recent Developments
 Table 111. Shin-Etsu Company Information
 Table 112. Shin-Etsu Description and Major Businesses
 Table 113. Shin-Etsu Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 114. Shin-Etsu Product Model Numbers, Pictures, Descriptions and Specifications
 Table 115. Shin-Etsu Recent Developments
 Table 116. Evonik Company Information
 Table 117. Evonik Description and Major Businesses
 Table 118. Evonik Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 119. Evonik Product Model Numbers, Pictures, Descriptions and Specifications
 Table 120. Evonik Recent Developments
 Table 121. Associated British Foods Company Information
 Table 122. Associated British Foods Description and Major Businesses
 Table 123. Associated British Foods Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 124. Associated British Foods Product Model Numbers, Pictures, Descriptions and Specifications
 Table 125. Associated British Foods Recent Developments
 Table 126. Südzucker AG Company Information
 Table 127. Südzucker AG Description and Major Businesses
 Table 128. Südzucker AG Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 129. Südzucker AG Product Model Numbers, Pictures, Descriptions and Specifications
 Table 130. Südzucker AG Recent Developments
 Table 131. Mitsubishi Company Information
 Table 132. Mitsubishi Description and Major Businesses
 Table 133. Mitsubishi Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 134. Mitsubishi Product Model Numbers, Pictures, Descriptions and Specifications
 Table 135. Mitsubishi Recent Developments
 Table 136. Hunan ER-KANG Company Information
 Table 137. Hunan ER-KANG Description and Major Businesses
 Table 138. Hunan ER-KANG Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 139. Hunan ER-KANG Product Model Numbers, Pictures, Descriptions and Specifications
 Table 140. Hunan ER-KANG Recent Developments
 Table 141. Anhui Sunhere Company Information
 Table 142. Anhui Sunhere Description and Major Businesses
 Table 143. Anhui Sunhere Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 144. Anhui Sunhere Product Model Numbers, Pictures, Descriptions and Specifications
 Table 145. Anhui Sunhere Recent Developments
 Table 146. Tianjin Chase Sun Company Information
 Table 147. Tianjin Chase Sun Description and Major Businesses
 Table 148. Tianjin Chase Sun Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 149. Tianjin Chase Sun Product Model Numbers, Pictures, Descriptions and Specifications
 Table 150. Tianjin Chase Sun Recent Developments
 Table 151. Xiwang Group Company Information
 Table 152. Xiwang Group Description and Major Businesses
 Table 153. Xiwang Group Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 154. Xiwang Group Product Model Numbers, Pictures, Descriptions and Specifications
 Table 155. Xiwang Group Recent Developments
 Table 156. ShengTai Group Company Information
 Table 157. ShengTai Group Description and Major Businesses
 Table 158. ShengTai Group Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 159. ShengTai Group Product Model Numbers, Pictures, Descriptions and Specifications
 Table 160. ShengTai Group Recent Developments
 Table 161. Nanjing Well Pharmaceutical Company Information
 Table 162. Nanjing Well Pharmaceutical Description and Major Businesses
 Table 163. Nanjing Well Pharmaceutical Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 164. Nanjing Well Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 165. Nanjing Well Pharmaceutical Recent Developments
 Table 166. Key Raw Materials Lists
 Table 167. Raw Materials Key Suppliers Lists
 Table 168. Distributors List
 Table 169. Customers List
 Table 170. Market Trends
 Table 171. Market Drivers
 Table 172. Market Challenges
 Table 173. Market Restraints
 Table 174. Research Programs/Design for This Report
 Table 175. Key Data Information from Secondary Sources
 Table 176. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharmaceutical Excipients Product Picture
 Figure 2. Global Pharmaceutical Excipients Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Pharmaceutical Excipients Market Share by Type: 2024 & 2031
 Figure 4. Starch and Derivatives Product Picture
 Figure 5. Sucrose Product Picture
 Figure 6. Cellulose and Derivatives Product Picture
 Figure 7. Dextrose Product Picture
 Figure 8. Polyols Product Picture
 Figure 9. Inorganic Salts Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Pharmaceutical Excipients Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Pharmaceutical Excipients Market Share by Application: 2024 & 2031
 Figure 13. Oral Formulations
 Figure 14. Topical Formulations
 Figure 15. Parenteral Formulations
 Figure 16. Other
 Figure 17. Pharmaceutical Excipients Report Years Considered
 Figure 18. Global Pharmaceutical Excipients Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 20. Global Pharmaceutical Excipients Revenue by Region (2020-2031) (US$ Million)
 Figure 21. Global Pharmaceutical Excipients Revenue Market Share by Region in Percentage: 2024 Versus 2031
 Figure 22. Global Pharmaceutical Excipients Revenue Market Share by Region (2020-2031)
 Figure 23. Global Pharmaceutical Excipients Sales (2020-2031) & (K Tons)
 Figure 24. Global Pharmaceutical Excipients Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Tons)
 Figure 25. Global Pharmaceutical Excipients Sales Market Share by Region (2020-2031)
 Figure 26. US & Canada Pharmaceutical Excipients Sales YoY (2020-2031) & (K Tons)
 Figure 27. US & Canada Pharmaceutical Excipients Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. Europe Pharmaceutical Excipients Sales YoY (2020-2031) & (K Tons)
 Figure 29. Europe Pharmaceutical Excipients Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. China Pharmaceutical Excipients Sales YoY (2020-2031) & (K Tons)
 Figure 31. China Pharmaceutical Excipients Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. Asia (excluding China) Pharmaceutical Excipients Sales YoY (2020-2031) & (K Tons)
 Figure 33. Asia (excluding China) Pharmaceutical Excipients Revenue YoY (2020-2031) & (US$ Million)
 Figure 34. Middle East, Africa and Latin America Pharmaceutical Excipients Sales YoY (2020-2031) & (K Tons)
 Figure 35. Middle East, Africa and Latin America Pharmaceutical Excipients Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Global Pharmaceutical Excipients Sales Share by Manufacturers (2024)
 Figure 37. The Pharmaceutical Excipients Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
 Figure 38. Global Pharmaceutical Excipients Revenue Share by Manufacturers (2024)
 Figure 39. The Top 5 and 10 Largest Manufacturers of Pharmaceutical Excipients in the World: Market Share by Pharmaceutical Excipients Revenue in 2024
 Figure 40. Global Pharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 41. Global Pharmaceutical Excipients Sales Market Share by Type (2020-2031)
 Figure 42. Global Pharmaceutical Excipients Revenue Market Share by Type (2020-2031)
 Figure 43. Global Pharmaceutical Excipients Sales Market Share by Application (2020-2031)
 Figure 44. Global Pharmaceutical Excipients Revenue Market Share by Application (2020-2031)
 Figure 45. US & Canada Pharmaceutical Excipients Sales Market Share by Type (2020-2031)
 Figure 46. US & Canada Pharmaceutical Excipients Revenue Market Share by Type (2020-2031)
 Figure 47. US & Canada Pharmaceutical Excipients Sales Market Share by Application (2020-2031)
 Figure 48. US & Canada Pharmaceutical Excipients Revenue Market Share by Application (2020-2031)
 Figure 49. US & Canada Pharmaceutical Excipients Revenue Share by Country (2020-2031)
 Figure 50. US & Canada Pharmaceutical Excipients Sales Share by Country (2020-2031)
 Figure 51. US Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 52. Canada Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 53. Europe Pharmaceutical Excipients Sales Market Share by Type (2020-2031)
 Figure 54. Europe Pharmaceutical Excipients Revenue Market Share by Type (2020-2031)
 Figure 55. Europe Pharmaceutical Excipients Sales Market Share by Application (2020-2031)
 Figure 56. Europe Pharmaceutical Excipients Revenue Market Share by Application (2020-2031)
 Figure 57. Europe Pharmaceutical Excipients Sales Share by Country (2020-2031)
 Figure 58. Europe Pharmaceutical Excipients Revenue Share by Country (2020-2031)
 Figure 59. Germany Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 60. France Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 61. U.K. Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 62. Italy Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 63. Russia Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 64. China Pharmaceutical Excipients Sales Market Share by Type (2020-2031)
 Figure 65. China Pharmaceutical Excipients Revenue Market Share by Type (2020-2031)
 Figure 66. China Pharmaceutical Excipients Sales Market Share by Application (2020-2031)
 Figure 67. China Pharmaceutical Excipients Revenue Market Share by Application (2020-2031)
 Figure 68. Asia Pharmaceutical Excipients Sales Market Share by Type (2020-2031)
 Figure 69. Asia Pharmaceutical Excipients Revenue Market Share by Type (2020-2031)
 Figure 70. Asia Pharmaceutical Excipients Sales Market Share by Application (2020-2031)
 Figure 71. Asia Pharmaceutical Excipients Revenue Market Share by Application (2020-2031)
 Figure 72. Asia Pharmaceutical Excipients Revenue Share by Region (2020-2031)
 Figure 73. Asia Pharmaceutical Excipients Sales Share by Region (2020-2031)
 Figure 74. Japan Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 75. South Korea Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 76. China Taiwan Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 77. Southeast Asia Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 78. India Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 79. Australia Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 80. Middle East, Africa and Latin America Pharmaceutical Excipients Sales Market Share by Type (2020-2031)
 Figure 81. Middle East, Africa and Latin America Pharmaceutical Excipients Revenue Market Share by Type (2020-2031)
 Figure 82. Middle East, Africa and Latin America Pharmaceutical Excipients Sales Market Share by Application (2020-2031)
 Figure 83. Middle East, Africa and Latin America Pharmaceutical Excipients Revenue Market Share by Application (2020-2031)
 Figure 84. Middle East, Africa and Latin America Pharmaceutical Excipients Revenue Share by Country (2020-2031)
 Figure 85. Middle East, Africa and Latin America Pharmaceutical Excipients Sales Share by Country (2020-2031)
 Figure 86. Brazil Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 87. Mexico Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 88. Turkey Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 89. Israel Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 90. GCC Countries Pharmaceutical Excipients Revenue (2020-2031) & (US$ Million)
 Figure 91. Value Chain
 Figure 92. Pharmaceutical Excipients Production Process
 Figure 93. Channels of Distribution (Direct Vs Distribution)
 Figure 94. Bottom-up and Top-down Approaches for This Report
 Figure 95. Data Triangulation
 Figure 96. Key Executives Interviewed